Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects

Dan Jones; Su S. Chen; Elias Jabbour; Mary Beth Rios; Hagop Kantarjian; Jorge Cortes

doi:10.1182/blood-2009-11-252155

Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph⁺ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects

Dan Jones, Su S. Chen, Elias Jabbour, Mary Beth Rios, Hagop Kantarjian, Jorge Cortes

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	5428-5429
Number of pages	2
Journal	Blood
Volume	115
Issue number	26
DOIs	https://doi.org/10.1182/blood-2009-11-252155
State	Published - Jul 1 2010
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2009-11-252155

Cite this

Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph⁺ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects. / Jones, Dan; Chen, Su S.; Jabbour, Elias et al.
In: Blood, Vol. 115, No. 26, 01.07.2010, p. 5428-5429.

Research output: Contribution to journal › Letter › peer-review

@article{133c163965dc43419fd673d049cd5051,

title = "Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects",

author = "Dan Jones and Chen, {Su S.} and Elias Jabbour and Rios, {Mary Beth} and Hagop Kantarjian and Jorge Cortes",

year = "2010",

month = jul,

day = "1",

doi = "10.1182/blood-2009-11-252155",

language = "English (US)",

volume = "115",

pages = "5428--5429",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "26",

}

TY - JOUR

T1 - Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects

AU - Jones, Dan

AU - Chen, Su S.

AU - Jabbour, Elias

AU - Rios, Mary Beth

AU - Kantarjian, Hagop

AU - Cortes, Jorge

PY - 2010/7/1

Y1 - 2010/7/1

UR - http://www.scopus.com/inward/record.url?scp=77955863869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955863869&partnerID=8YFLogxK

U2 - 10.1182/blood-2009-11-252155

DO - 10.1182/blood-2009-11-252155

M3 - Letter

C2 - 20595523

AN - SCOPUS:77955863869

SN - 0006-4971

VL - 115

SP - 5428

EP - 5429

JO - Blood

JF - Blood

IS - 26

ER -

Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph⁺ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects